Ronny Bruffærts|Gemma Vilagut|Koen Demyttenaere|Jordi Alonso|Ali Al?Hamzawi|Laura Helena Andrade|Corina Benjet|Evelyn J. Bromet|Brendan Bunting|Giovanni de Girolamo|Silvia Florescu|Oye Gureje|Josep María Haro|Yi He|Hristo Hinkov|Chiyi Hu|Elie G. Karam|Jean Pierre Lépine|Daphna Levinson|Herbert Matschinger|Yoshibumi Nakane|Johan Ormel|José Posada?Villa|Kate M. Scott|Mathew Varghese|David R. Williams|Miguel Xavier|Ronald C. Kessler
Role of common mental and physical disorders in partial disability around the world
Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Pfizer (United Kingdom)|Sanofi (France)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente|Sanofi (France)|Pfizer (United Kingdom)|Kaiser Permanente
mental physical disorders associated total disability effects days partial disability ie ability perform fullrole functioning daily life well understoodto estimate individual ie consequences individual disorder societal effects ie avoidable partial disability society due disorders mental physical disorders days partial disability around worldrespondents 26 nationally representative samples n 61 259 age 18 interviewed regarding mental physical disorders daytoday functioning composite international diagnostic interview version 30 cidi 30 used assess mental disorders partial disability expressed full day equivalents assessed world health organization disability assessment schedule cidi 30respondents disorders reported 158 additional disability days per month compared respondents without disorders individual level mental disorders especially posttraumatic stress disorder depression bipolar disorder yielded higher number days disability physical disorders societal level population attributable risk proportion due physical mental disorders 49 15 respectivelymental physical disorders considerable impact partial disability individual societal level physical disorders yielded higher effects partial disability mental disorders